High school students get stem cell experience in California labs
Posted: August 12, 2011
UUniversity of California Davis
UTop questions in iPS cell research
Posted: August 11, 2011
Every once in a while CIRM grantee Paul Knoepfler at UC Davis posts an update on his blog about what he considers to be the big ticket question in research using reprogrammed adult cells, known as iPS cells. This time, he's posted five questions for the upcoming year.
- Read more about Top questions in iPS cell research
- Log in to post comments
A welcome voice in stem cell communication - a new podcast launches
Posted: July 6, 2011
CIRM grantee Paul Knoepfler at UC Davis has been blogging about stem cell science for a while now. He recently expanded his outreach to include a regular podcast. It's worth checking out. He's listing the most recent podcast at the top of his main blog page: http://www.ipscell.com/ .
Blood from stem cells?
Posted: June 8, 2011
Blood has been among the most sought after and hardest to achieve tissue that CIRM grantees are attempting to derive from embryonic stem cells. It's an obvious target. The medical system needs a constant influx of blood, which comes entirely from volunteer donors. Creating that blood in an unlimited supply from human embryonic stem cells would significantly ease concerns about blood shortages at hospitals.
- Read more about Blood from stem cells?
- Log in to post comments
CIRM a leader in iPS cell publications
Posted: April 21, 2011
Yesterday, stem cell blogger and newly tenured CIRM grantee at UC Davis Paul Knoepfler had an interesting blog entry on iPS cell publications.
- Read more about CIRM a leader in iPS cell publications
- Log in to post comments
CIRM grantees begin testing stem cells to prevent amputations
Posted: March 22, 2011
CIRM grantees at UC Davis have begun a trial that, if successful, could help prevent some amputations caused by blockages in the blood vessels.
UC Davis scientist on a quest for cures in the cleanest of labs
Posted: February 18, 2011
 |
Stem cell research like picking stocks? We don't think so.
Posted: November 10, 2010
A story by Nick Wade in Monday's New York Times rubbed some scientists the wrong way - and I must admit the piece was not too popular around CIRM headquarters.
Wade equated research funding with picking stocks. His idea is that a broad portfolio is bound to include some winners (he attributes this approach to the NIH and NSF) whereas attempts to only buy the big winners can produce a risky portfolio (an approach he attributes to CIRM).
Wade equated research funding with picking stocks. His idea is that a broad portfolio is bound to include some winners (he attributes this approach to the NIH and NSF) whereas attempts to only buy the big winners can produce a risky portfolio (an approach he attributes to CIRM).
Federal stem cell legislation unlikely in lame duck session
Posted: November 3, 2010
Science had a story this morning about what yesterday's elections mean for stem cell funding. In it they suggest it's unlikely that the lame duck congressional session will bring legislation to expressly legalize federal funding for human embryonic stem cell research, writing:
Growing space for California stem cell research
Posted: October 15, 2010
 |
| On left and right, Berkeley Stem Cell Center co-directors David Schaffer and Randy Shekman, and center, |
- Read more about Growing space for California stem cell research
- Log in to post comments